Send us Feedback

ACADIA Pharmaceuticals (ACAD)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ACAD » Topics » Item 11. Executive Compensation .

This excerpt taken from the ACAD 10-K filed Mar 10, 2009.

Item 11. Executive Compensation.

The information required by this Item will be set forth in the section headed “Executive Compensation” in our Proxy Statement and is incorporated in this report by reference.

These excerpts taken from the ACAD 10-K filed Mar 5, 2008.

Item 11. Executive Compensation.

The information required by this Item will be set forth in our Proxy Statement and is incorporated in this report by reference.


Item 11. Executive Compensation.

The information required by this Item will be set
forth in our Proxy Statement and is incorporated in this report by reference.

This excerpt taken from the ACAD 10-K filed Mar 9, 2007.

Item 11. Executive Compensation.

The information required by this Item will be set forth in our Proxy Statement and is incorporated in this report by reference.

This excerpt taken from the ACAD 10-K filed Mar 15, 2006.

Item 11. Executive Compensation.

The information required by this Item will be set forth in the section headed “Executive Compensation and Other Information” in the Proxy Statement and is incorporated in this report by reference.

This excerpt taken from the ACAD 10-K filed Mar 18, 2005.

Item 11. Executive Compensation

 

The information required by this Item will be set forth in the section headed “Executive Compensation and Other Information” in the Proxy Statement and is incorporated in this report by reference.

 

EXCERPTS ON THIS PAGE:

10-K
Mar 10, 2009
10-K (2 sections)
Mar 5, 2008
10-K
Mar 9, 2007
10-K
Mar 15, 2006
10-K
Mar 18, 2005

RELATED TOPICS for ACAD:

"Item 11. Executive Compensation ." elsewhere:

ARIAD Pharmaceuticals (ARIA)
BioCryst Pharmaceuticals (BCRX)
Corcept Therapeutics (CORT)
EPIX Pharmaceuticals (EPIX)
EXACT Sciences (EXAS)
GenVec (GNVC)
GTC Biotherapeutics (GTCB)
IGI (IG)
Metabasis Therapeutics (MBRX)
Memory Pharmaceuticals (MEMY)
Molecular Insight Pharmaceuticals (MIPI)
Micromet (MITI)
Matritech (MZT)
Biota Pharmaceuticals, Inc. (NABI)
Neose Technologies (NTEC)
Neurobiological Technologies (NTII)
Osiris Therapeutics (OSIR)
Pharmacopeia Drug Discovery (PCOP)
Peregrine Pharmaceuticals (PPHM)
Sangamo BioSciences (SGMO)
Sunesis Pharmaceuticals (SNSS)
StemCells (STEM)
Savient Pharmaceuticals (SVNT)
AmpliPhi Biosciences Corp (TGEN)
Theravance (THRX)
SYNAGEVA BIOPHARMA CORP (TRMS)
Vical (VICL)
ZIOPHARM ONCOLOGY (ZIOP)
CORD BLOOD AMERICA (CBAI)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki